Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendation for the management of dyslipidemia in Poland - Third Declaration of Sopot. Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
Szymański FM, Barylski M, Cybulska B, Wożakowska-Kapłon B, Krasiński Z, Mamcarz A, Widecka K, Płatek AE, Dudek D, Mickiewicz A, Kobayashi A, Dzida G, Grajek S, Wełnicki M, Zubilewicz T, Ufnal M, Hering D, Mizia-Stec K, Kasprzak J, Koziński M, Imiela J, Narkiewicz K, Gorczyca I, Postuła M, Jaguszewski MJ, Filipiak KJ. Szymański FM, et al. Among authors: welnicki m. Cardiol J. 2018;25(6):655-665. doi: 10.5603/CJ.2018.0141. Cardiol J. 2018. PMID: 30600830 Free article. Review. No abstract available.
[New versus classic risk factors].
Wełnicki M, Mamcarz A. Wełnicki M, et al. Kardiol Pol. 2010 Nov;68(11):1225. Kardiol Pol. 2010. PMID: 21108197 Polish. No abstract available.
Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot.
Szymański FM, Mickiewicz A, Dzida G, Gorczyca-Głowacka I, Kozłowski D, Widecka K, Krasiński Z, Kobayashi A, Hering D, Mizia-Stec K, Kasprzak JD, Zubilewicz T, Narkiewicz K, Koziński M, Płatek AE, Ryś-Czaporowska A, Chełstowska B, Grajek S, Wełnicki M, Mamcarz A, Barylski M, Wożakowska-Kapłon B, Jaguszewski MJ, Gruchała M, Filipiak KJ. Szymański FM, et al. Among authors: welnicki m. Cardiol J. 2022;29(1):1-26. doi: 10.5603/CJ.a2021.0147. Epub 2021 Nov 23. Cardiol J. 2022. PMID: 34811718 Free PMC article. No abstract available.
The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society.
Wełnicki M, Gorczyca-Głowacka I, Mamcarz A, Filipiak KJ, Wożakowska-Kapłon B, Barylski M, Szymański FM, Kasprzak JD, Grabowski M, Dzida G. Wełnicki M, et al. Kardiol Pol. 2022;80(12):1286-1289. doi: 10.33963/KP.a2022.0282. Kardiol Pol. 2022. PMID: 36601885 Free article. No abstract available.
Rules for the use of reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society.
Gorczyca-Głowacka I, Kapłon-Cieślicka A, Wełnicki M, Szymański F, Barylski M, Mamcarz A, Filipiak KJ, Wożakowska-Kapłon B. Gorczyca-Głowacka I, et al. Among authors: welnicki m. Kardiol Pol. 2022;80(12):1299-1306. doi: 10.33963/KP.a2022.0286. Kardiol Pol. 2022. PMID: 36601886 Free article. No abstract available.
Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society.
Gorczyca-Głowacka I, Wełnicki M, Mamcarz A, Filipiak KJ, Wożakowska-Kapłon B, Barylski M, Szymański FM, Kasprzak JD, Tomasiewcz K. Gorczyca-Głowacka I, et al. Among authors: welnicki m. Kardiol Pol. 2023;81(2):207-214. doi: 10.33963/KP.a2023.0022. Kardiol Pol. 2023. PMID: 36866400 Free article.
46 results